Cargando…
Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
OBJECTIVE: Although β-blockers are an established therapy in heart failure (HF) guidelines, including for patients with chronic obstructive pulmonary disease (COPD), there remain concerns regarding bronchoconstriction even with cardioselective β-blockers. We wished to assess the real-life use of β-b...
Autores principales: | Lipworth, Brian, Skinner, Derek, Devereux, Graham, Thomas, Victoria, Ling Zhi Jie, Joanna, Martin, Jessica, Carter, Victoria, Price, David B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136686/ https://www.ncbi.nlm.nih.gov/pubmed/27380949 http://dx.doi.org/10.1136/heartjnl-2016-309458 |
Ejemplares similares
-
Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy
por: Javidgonbadi, Davood, et al.
Publicado: (2019) -
Relationships among achieved heart rate, β-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation
por: Miller, Robert J H, et al.
Publicado: (2016) -
EFFECTS OF COVID-19 ON HEART FAILURE ADMISSIONS IN NYC
por: Friedman, Ari, et al.
Publicado: (2021) -
Improving the diagnosis of heart failure in patients with atrial fibrillation
por: Bunting, Karina V, et al.
Publicado: (2021) -
SOCIODEMOGRAPHIC DIFFERENCES IN THE UTILIZATION OF REMOTE PULMONARY ARTERY PRESSURE MEASUREMENTS FOR HEART FAILURE PATIENTS IN THE USA
por: Markson, Favour, et al.
Publicado: (2023)